iShares Biotechnology ETF $IBB Position Lifted by World Investment Advisors

World Investment Advisors raised its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 50.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,853 shares of the financial services provider’s stock after purchasing an additional 3,973 shares during the period. World Investment Advisors’ holdings in iShares Biotechnology ETF were worth $2,001,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Allspring Global Investments Holdings LLC grew its position in iShares Biotechnology ETF by 46,806.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock valued at $7,927,000 after buying an additional 46,806 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new position in iShares Biotechnology ETF in the third quarter valued at about $1,907,000. Tudor Investment Corp ET AL bought a new position in iShares Biotechnology ETF during the third quarter valued at approximately $931,000. WorthPointe LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at $1,424,000. Finally, Central Pacific Bank Trust Division lifted its holdings in iShares Biotechnology ETF by 296,500.0% in the 4th quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock worth $2,503,000 after purchasing an additional 14,825 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $173.64 on Friday. iShares Biotechnology ETF has a 1 year low of $123.61 and a 1 year high of $179.64. The firm’s fifty day simple moving average is $170.61 and its 200 day simple moving average is $170.66.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were issued a dividend of $0.0238 per share. The ex-dividend date was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a dividend yield of 0.1%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.